Skip to content

Apotheek De Gendt

Active
Private limited companyfounded 1981active for 44 yearsOogststraat 9, 2600 Antwerpen, BelgiumKBO/BCE: BE 0422.288.609

From the official registers: KBO 44 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek De Gendt has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €148,985 and a net result of €102,935. Equity has been stable since 2018 (±0.6% per year). Its solvency ranks better than 39% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisFollow ReportCompare
Apotheek De GendtActiveChecked score 83/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 31-12-1981 Normal situation
Legal form
Private limited company
Registered office
Oogststraat 9, 2600 Antwerpen
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.019.803.284 2600 Antwerpen, since 15-01-1982
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Board and ownership

Board
  • GEORGES PILULEDirector · since 01-01-2018 · permanent representative DE GENDT Caroline
Shareholders
Board & ownership

Financial position

83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Annual accounts 2025
Gross margin
€360,393
▲ 10.4%
Turnover
≈ €1.3m
estimated
Profit
€102,935
▲ 6.0%
Equity
€148,985
▼ 39.4%
Total assets
€551,792
▼ 10.6%
Staff
2.3 FTE
▲ 15.0%
2025 accounts filed 51 days before the deadline
Filed on 10-06-2026PDF
Financials
Score breakdownraises riskSector: Retail trade (NACE 47)Liquidity: current ratio 1.22, cash €9,391, halvedlowers riskFounded in 1981Size: 2.3 FTE, total assets €551,792Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 40% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Average
Solvency 52-13
equity 27.0% of total assets
Liquidity 27-11
short-term debt 50.4% · cash 1.7%
Profitability 87+5
return on assets 18.7%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.4%● unchanged vs 07-2026highest value 09-2026: 0.4%● unchanged vs 08-2026highest value 10-2026: 0.4%● unchanged vs 09-2026highest value
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.22 (1.72 in 2024), below the usual 1.5. Short-term debt is 50.4% and cash 1.7% of total assets. 73% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 43% of them on solvency, 24% on liquidity, 82% on profitability and 13% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1981
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Liquidity: current ratio 1.22, cash €9,391, halved
NBB · annual accounts
lowers risk · Size: 2.3 FTE, total assets €551,792
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 days early
2024
43 days early
2023
36 days early
2022
41 days early
2021
53 days early
2020
17 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 30 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €102,935 8 years View
  • Caution: Equity fell in 2025from €246,050 to €148,985 ▼ 39.4% View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Documents

Annual accounts at the NBB

All 44 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek De Gendt

What is the company number of Apotheek De Gendt?
The company number of Apotheek De Gendt is 0422.288.609. The VAT number is the same number with BE in front: BE 0422.288.609.
Where is Apotheek De Gendt based?
The registered office is at Oogststraat 9, 2600 Antwerpen.Company details
What does Apotheek De Gendt do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Gendt?
The legal form of Apotheek De Gendt is Private limited company (BV).
When was Apotheek De Gendt founded?
Apotheek De Gendt was founded on 31-12-1981.
Is Apotheek De Gendt still active?
Yes, Apotheek De Gendt is an active enterprise in the KBO register.
How many employees does Apotheek De Gendt have?
Apotheek De Gendt had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek De Gendt?
The turnover in financial year 2025 is ≈ €1.3m. This figure is estimated from the gross margin of €360,393 and 47 comparable companies (NACE 477). It probably lies between €1.0m and €2.2m.
Is Apotheek De Gendt profitable?
In financial year 2025, Apotheek De Gendt made a profit of €102,935.
Where can I find the annual accounts of Apotheek De Gendt?
Apotheek De Gendt filed 44 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek De Gendt due?
Apotheek De Gendt must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Companies linked to Apotheek De Gendt

Comparable companies

These companies have the same main activity as Apotheek De Gendt: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €610,000 and €665,000, founded between 1981 and 1985.

CompanyTotal assetsGross margin
Apotheek De Gendt Antwerpen€551,792€360,393
Apoteek Francois Hechtel-Eksel€609,692€367,729
APOTHEEK VAN HULST Antwerpen€613,381€285,328
Apoteek Coppens Haaltert€635,784€337,780
HENRION-FOUREZ Brunehaut€661,950€341,915
APOTHEEK MINNAERT Oosterzele€635,368€386,273
PHARMACIE VERSCHUERE Mouscron€665,366€393,893
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure